Advertisement
Verve Therapeutics, Inc. (VERV)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 4.6000 |
| Open | 4.5000 |
| Bid | 4.8200 x 500 |
| Ask | 4.8700 x 500 |
| Day's Range | 4.5000 - 4.8650 |
| 52 Week Range | 4.3050 - 19.3400 |
| Volume | |
| Avg. Volume | 1,394,350 |
| Market Cap | 410.619M |
| Beta (5Y Monthly) | 1.76 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.4600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.20 |
Simply Wall St.Verve Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Verve Therapeutics ( NASDAQ:VERV ) Third Quarter 2024 Results Key Financial Results Revenue: US$6.87m (up 120% from 3Q...
ZacksVerve Therapeutics (VERV) Reports Q3 Loss, Tops Revenue Estimates
Verve Therapeutics (VERV) delivered earnings and revenue surprises of 15.71% and 13.47%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.